deutsch
Congresses
We will present our company and our products at the following congresses:
Birmingham ICC, UK
Kuala Lumpur, Malaysia
Chicago, USA
DDF Meeting 2012
June 17 - June 20, 2012
Liverpool, UK
Focus 2012
May 1 – May 3, 2012
Liverpool, UK
NCRI Cancer Conference 2011
Nov 6 – Nov 8, 2011
Liverpool, UK
Biomedical Science Congress 2011
Sep 26 - Sep 28, 2011Birmingham ICC, UK
GUT 2011, Annual Meeting of the Malaysian Society of Gastroenterology and Hepatology
May 27 - May 29, 2011Kuala Lumpur, Malaysia
DDW 2011
May 7- May 11, 2011Chicago, USA
AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
read...
read...
Lecture DDW 2011: New molecular markers: M2-PK
Lecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011.
read...
read...
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in ′Science′
read...
read...
Video: Focus 2010 lecture on M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010
read...
read...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
read...
read...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
read...
read...